Biotechnology News

INFORMATION REGLEMENTEE : PERMANENTE Titre concerné : CARBIOS (code ISIN FR0011648716) / Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 17 juillet 2026 (18h00 CEST). CARBIOS...

REGULATED INFORMATION: ONGOING Shares concerned: Carbios (ISIN code: FR0011648716) / Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 17 July 2026 (18:00 CEST). CARBIOS, (Euronext...

Houston, Texas and Tuebingen, Germany, July 17, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage...

TORONTO, July 17, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (TSX Venture: ARCH and OTCQB: ACHFF) today announced that it has engaged a U.S.-based laboratory specializing in bioengineering to...

Joint presentation with Taipei Medical University, JY BioMed, and HeXun Biosciences highlighted the power of gamma delta (γδ) T cells in eliminating glioblastoma in preclinical studies. TAIPEI,...

SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell...

Three-year data from phase 2 trial will provide additional insights into potentially enhanced treatment effects and durability of the EVX-01-induced immune responseData will also offer insight into...

Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline.

Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven disorders  Concurrent $132 million private investment...

Cellution Biologics signs definitive agreement to acquire SimpliDerm®, expanding its allograft portfolio and entering the U.S. breast reconstruction market